The Eijkman‐Oxford Clinical Research Unit (EOCRU) opened in 2007 by formal agreement between the Eijkman Institute of Molecular Biology (EIMB) and the University of Oxford. These institutions now collaborate in clinical, laboratory, and field research on infectious diseases of public health importance in Indonesia.
EOCRU scientists and technologists engage principally in a wide array of endeavors involving various problems with Plasmodium vivax malaria. While we utilize a variety of sophisticated laboratory techniques, the emphasis of the vitally important capacity‐building aspect of our work focuses on people in defined roles as members of a clinical research team. The biotechnological capacity of EIMB exceeds that of EOCRU and we rely on that partner in that arena. In response to growing commitments to the conduct of clinical trials, EOCRU has also partners with the University of Indonesia (FKUI). This tri-partite partnership means that EOCRU is ideally positioned for realization of its “bench to bedside” research vision.
The vision of EOCRU is to facilitate the creation of a clinical research capacity within the EIMB and on the campus of FKUI leveraging state-of-the-art clinical/medical facilities at FKUI in managing patients in research and trials, and capitalizing the state-of-the-art biotechnological/scientific facilities at EIMB for maximum impact on human health, particularly the health of Indonesians.
Head Unit : Prof. J. Kevin Baird
Secretary to Head Unit: I.D.A.Y.R. Chrisverani
Research and Grand Administrator : Fitria Wulandari
Health System and Data Management
Bio-statistics and Spatial Mapping
Clinical Research Scientist